Oragenics Inc. (OGEN) Dividend History

Oragenics Inc. (OGEN) is a biotechnology company focused on developing innovative vaccines and antibiotics to combat infectious diseases. The company primarily works on probiotics and therapeutic products to address bacterial infections and enhance immune responses, aiming to improve public health outcomes through novel microbial-based solutions.

Dividend History

Oragenics Inc. currently does not pay dividends

Company News

  • Oragenics, Inc. has submitted a clinical trial protocol for regulatory review to the Health and Disability Ethics Committee in New Zealand for its Phase II trial evaluating ONP-002, a proprietary neurosteroid therapy, for the treatment of mild traumatic brain injury or concussion.

    GlobeNewswire Inc.
  • Oragenics, a biopharmaceutical company, has postponed its 2023 Annual Meeting of Shareholders, previously scheduled for August 26, 2024. The company stated that a new meeting date will be set and communicated in the future.

    Investing.com
  • U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors   Real estate shares rose by 1.4% on Wednesday. In trading on Wednesday, communication services shares fell by 0.8%.   Top Headline   ADT Inc. (NYSE: ADT) reported better-than-expected earnings for its fourth quarter on Wednesday. ADT posted fourth-quarter fiscal 2023 sales decline of 7.2% year-on-year to $1.22 billion, missing the consensus of $1.44 billion. Adjusted EPS was 25 cents, beating the consensus of 4 cents. ADT expects CSB segment revenue of 4.8 billion-$5.0 billion. The company expects adjusted EPS of $0.60 – $0.70, against consensus of $0.50.   Equities Trading UP   Vivani Medical, Inc. (NASDAQ: VANI) shares shot up 274% to $3.78 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Shares of Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) got a boost, surging 159% to $2.1917. ...

    Benzinga
    Featured Companies: ADIL ADT IAS INGN VANI VTVT
  • Penny stocks to buy under $1: A Beginner's Guide The post Trading Penny Stocks Under $1: Strategies for Success & 7 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AGFY PGY SHIP
  • Companies in the news are: DSPG, IDEX, OGEN, AFRM

    Zacks Investment Research
    Featured Companies: AFRM
Page data last updated 07/23/2025 02:07:35 UTC